Colorectal polyps
Conditions
Interventions
experimental group:Antiplatelet therapy resumed the following day.
control group:Antiplatelet therapy will be scheduled for the next day.
Sponsors
The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years, scheduled for elective colorectal polyp resection. 2. Long-term antiplatelet therapy (aspirin or P2Y12 inhibitor monotherapy). 3. Polyps assessed as suitable for complete endoscopic resection. 4. Stable clinical condition, able to tolerate endoscopic procedures. 5. Signed informed consent form, agreeing to participate in this study and accept follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients who have recently undergone coronary stent implantation (within 6 months) and require mandatory maintenance of dual antiplatelet therapy. 2. Patients taking oral anticoagulants (warfarin or DOACs) and are unable to discontinue or adjust their medication. 3. High-risk procedures requiring polyp diameter >20 mm or requiring piecemeal resection/ESD. 4. Patients with severe liver or kidney dysfunction, coagulation disorders, or active bleeding. 5. Pregnant or lactating women. 6. Patients unable to complete follow-up or with poor adherence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of postoperative bleeding risk; | — |
Secondary
| Measure | Time frame |
|---|---|
| All-cause mortality rate;Readmission rate, readmission rate (endoscopy/intervention/surgery);Cardiovascular and cerebrovascular events 30 days after surgery; | — |
Countries
China
Contacts
Public ContactLu Chao
The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Outcome results
None listed